
    
      This is a prospective, phase II clinical trial to evaluate the efficacy and safety of
      induction chemotherapy with nedaplatin, docetaxel and 5-Fluorouracil followed by concurrent
      nedaplatin combined with radical radiotherapy in locally advanced nasopharyngeal carcinoma
      patients. This is a multicenter study. All patients will be enrolled in endemic area. All
      patients will receive radical intense modulate radiation therapy (IMRT). The primary endpoint
      is objective response rate (ORR).
    
  